Skip to main content

Baxter International statistics

  • BAX · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$25.81+0.27%Close 13 Nov 2026 · Market value $13.30B

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Baxter International is valued at $13.30B on its latest close.

Market value$13.30B
Enterprise value$20.18B
Price / sales1.15
Price / book2.05
EV / EBITDA27.50
EV / sales1.74
Price / free cash flow11.70
Price / free cash flow, own 5-year average29.52
EV / free cash flow17.71
Free cash flow yield8.5%
Dividend yield0.8%

Share price

Latest close$25.81
Day's change+0.3%
52-week high$30.00
52-week low$15.73
From 52-week high−14.0%
Return · 1 month+2.1%
Return · 3 months−2.3%
Return · year to date+35.1%
Return · 1 year+38.0%
Beta · 1 year against the S&P 5001.05
50-day average$24.54
200-day average$21.64
RSI 1454.3
Average volume · 20 sessions7.5M

Margins and returns

For fiscal 2025, as filed.

Gross margin30.1%
Operating margin−2.7%
Net margin−8.5%
Free cash flow margin3.0%
Return on equity−14.6%
Return on assets−1.1%
Return on invested capital−1.4%
Return on invested capital, 5-year average−0.3%
Return on capital employed−1.7%
Stock-based compensation / revenue1.0%

Financial position

At the end of fiscal 2025.

Cash and equivalents$1.97B
Total debt$9.78B
Net debt$7.81B
Current ratio2.31
Quick ratio0.99
Debt / equity1.60
Net debt / EBITDA11.61
Interest coverage−1.06

Growth

Revenue, latest quarter on a year+5.0%
Revenue, twelve months on a year+5.3%
Revenue, 5-year compound−0.7%
Revenue, 10-year compound+1.2%
Free cash flow, 5-year compound−22.1%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares513M
Shares outstanding, 5-year compound−0.2%
Net share repurchases−$30.00M
Dividends per share$0.52

Taxes

For fiscal 2025, as filed.

Income tax expense$395.0M
Effective tax rate−78.2%

BAX in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.